SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
latest_posts
- 1
I’m a dad to an autistic child. Here’s how you can make the holidays easier for all of us. - 2Do you lean your seat back on the plane? These travel pros — and real-life couple — won't do it.
- 3More people are addicted to marijuana, but fewer of them are seeking help, experts say
- 4Instructions to Amplify Certifiable Experience While Chasing after an Internet Advertising Degree
- 510 Famous Frozen yogurt Flavors All over The Planet
- Surveys of Music Collections by Film Stars
- The Best Web-based Courses for Expertise Improvement
- The Response to Self-improvement: Embracing a Development Outlook
- Support Your Body: A Manual for Smart dieting and Sustenance
- The most effective method to Beat Dental Tension and Guarantee Customary Exams
- Turkey's Erdogan denounces Israel-Greece-Cyprus trilateral summit, affirms support for Gaza
- Inside Plan with Houseplants: An Aide
- Revealing the Incomparable Realms: An Excursion through Power and Inheritance
- Our 10 favorite Space.com reader astronomy photos of 2025
